title: Thermochemotherapy of a human salivary adenocarcinoma cell line.
abstract: We report on thermochemotherapy in a human salivary gland adenocarcinoma cell line. Hyperthermia reduced the survival rate to 50 and 20% by heating at 43 degrees C for 40 and 60 min, respectively, and is by itself useful in human salivary gland carcinoma treatment. Adriamycin, cisplatin, and mitomycin C can possible be used clinically, while bleomycin and 5-fluorouracil cannot, to treat this carcinoma. The optimal temperature was considered to be 41 degrees C in adriamycin, 42 degrees C in cisplatin, 37 degrees C in mitomycin C, and 42 degrees C in bleomycin in the thermochemotherapy. Thermochemotherapy is a useful tool in the treatment of human salivary gland carcinoma cells, but it is necessary to select the best anticancer drugs and the optimal temperature for optimal success using this treatment.
authors.affiliation: Department of Oral and Maxillofacial Radiology, Field of Tumor Biology, Graduate School of Medicine and Dentistry, Okayama University Graduate Schools, Okayama 700-8525, Japan. asaumi@md.okayama-u.ac.jp
authors.forename: Jun-ichi
authors.initials: J
authors.lastname: Asaumi
authors.forename: Yuzuru
authors.initials: Y
authors.lastname: Higuchi
authors.forename: Hidenobu
authors.initials: H
authors.lastname: Matsuzaki
authors.forename: Jun
authors.initials: J
authors.lastname: Murakami
authors.forename: Shoji
authors.initials: S
authors.lastname: Kawasaki
authors.forename: Masahiro
authors.initials: M
authors.lastname: Kuroda
authors.forename: Koichi
authors.initials: K
authors.lastname: Shibuya
authors.forename: Hironobu
authors.initials: H
authors.lastname: Konouchi
authors.forename: Miki
authors.initials: M
authors.lastname: Hisatomi
authors.forename: Toru
authors.initials: T
authors.lastname: Wakasa
authors.forename: Kanji
authors.initials: K
authors.lastname: Kishi
authors.forename: Yoshio
authors.initials: Y
authors.lastname: Hiraki
mesh_terms: D000230:Adenocarcinoma / Q000473:pathology / Q000628:therapy*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001761:Bleomycin / Q000627:therapeutic use; D002470:Cell Survival / Q000187:drug effects; D002945:Cisplatin / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004317:Doxorubicin / Q000627:therapeutic use; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D006979:Hyperthermia, Induced; D016685:Mitomycin / Q000627:therapeutic use; D012468:Salivary Gland Neoplasms / Q000473:pathology / Q000628:therapy*; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000473:pathology
chemical_list: D000970:Antineoplastic Agents; D001761:Bleomycin; D016685:Mitomycin; D004317:Doxorubicin; D002945:Cisplatin; D005472:Fluorouracil